Up | AC Home Page

Gastrointestinal Drugs Advisory Committee 

 

January 23, 2008

 

  FDA

 

BRIEFING INFORMATION

 

FDA

Disclaimer

 

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §552). These redacted portions will appear as white space on the screen or on the printed page.

 

FDA Briefing Material (pdf)

 

Adolor Corporation

 

Disclaimer

 

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

 

Entereg® (Alvimopam) Capsules, Adolor Corporation Briefing Material (pdf)

---